160 related articles for article (PubMed ID: 35958842)
1. Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study.
Chua BWB; Neo P; Ma VY; Lim LM; Ng JSY; Wee HL
Front Public Health; 2022; 10():853453. PubMed ID: 35958842
[TBL] [Abstract][Full Text] [Related]
2. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
3. Barriers to cervical cancer prevention in rural Cameroon: a qualitative study on healthcare providers' perspective.
Roux AN; Kenfack B; Ndjalla A; Sormani J; Wisniak A; Tatrai K; Vassilakos P; Petignat P; Schmidt N
BMJ Open; 2021 Jun; 11(6):e043637. PubMed ID: 34140340
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore.
Tay SK; Lee BW; Sohn WY; Lee IH; Mathur G; Sanicas M; Van Kriekinge G
Singapore Med J; 2018 Jul; 59(7):370-382. PubMed ID: 28983579
[TBL] [Abstract][Full Text] [Related]
5. Understanding HPV-positive women's needs and experiences in relation to patient-provider communication issues: a qualitative study.
Qaderi K; Geranmayeh M; Farnam F; Sheikh Hasani S; Mirmolaei ST
BMC Health Serv Res; 2021 Mar; 21(1):286. PubMed ID: 33784992
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening among immigrant women in Norway- The healthcare providers' perspectives.
Møen KA; Terragni L; Kumar B; Diaz E
Scand J Prim Health Care; 2018 Dec; 36(4):415-422. PubMed ID: 30289317
[TBL] [Abstract][Full Text] [Related]
7. Female health-care providers' advocacy of self-sampling after participating in a workplace program for cervical cancer screening in Ghana: a mixed-methods study.
Behnke AL; Krings A; Wormenor CM; Dunyo P; Kaufmann AM; Amuah JE
Glob Health Action; 2020 Dec; 13(1):1838240. PubMed ID: 33200671
[TBL] [Abstract][Full Text] [Related]
8. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
9. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia.
Brandt T; Wubneh SB; Handebo S; Debalkie G; Ayanaw Y; Alemu K; Jede F; von Knebel Doeberitz M; Bussmann H
BMC Public Health; 2019 Jul; 19(1):1026. PubMed ID: 31366402
[TBL] [Abstract][Full Text] [Related]
10. HPV vaccination and cervical cancer screening promotion among Black individuals: social ecological perspectives from key informants interviews.
Adegboyega A; Adeyimika D; Omoadoni O; Mark D
Ethn Health; 2023 Oct; 28(7):1026-1040. PubMed ID: 36973897
[TBL] [Abstract][Full Text] [Related]
11. The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study.
Bavor C; Brotherton JM; Smith MA; Prang KH; McDermott T; Rankin NM; Zammit CM; Jennett CJ; Sultana F; Machalek DA; Nightingale CE;
BMC Health Serv Res; 2023 Oct; 23(1):1073. PubMed ID: 37803335
[TBL] [Abstract][Full Text] [Related]
12. Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study.
Bao H; Ma L; Zhao Y; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wu J; Wang HJ
Cancer Commun (Lond); 2022 Mar; 42(3):191-204. PubMed ID: 35142100
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
14. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
15. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
Lofters A; Devotta K; Prakash V; Vahabi M
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
[TBL] [Abstract][Full Text] [Related]
16. Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.
Roland KB; Benard VB; Greek A; Hawkins NA; Saraiya M
Vaccine; 2014 Sep; 32(42):5432-5. PubMed ID: 25131744
[TBL] [Abstract][Full Text] [Related]
17. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].
Ondryášová H; Koudeláková V; Drábek J; Vaněk P; Slavkovský R; Hajdúch M
Ceska Gynekol; 2015 Dec; 80(6):436-43. PubMed ID: 26741158
[TBL] [Abstract][Full Text] [Related]
18. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
[TBL] [Abstract][Full Text] [Related]
19. Cervical Cancer Prevention and High-Risk HPV Self-Sampling Awareness and Acceptability among Women Living with HIV: A Qualitative Investigation from the Patients' and Providers' Perspectives.
Le D; Coriolan Ciceron A; Jeon MJ; Gonzalez LI; Jordan JA; Bordon J; Long B
Curr Oncol; 2022 Jan; 29(2):516-533. PubMed ID: 35200547
[TBL] [Abstract][Full Text] [Related]
20. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
